The company will compete with a device Boston Scientific acquired for $850 million.

Boston Scientific ... rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment ...

TFC Financial Management Inc. raised its holdings in Boston Scientific by 308.8% during the ... movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Boston Scientific Corporation develops ... and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

Casma Therapeutics, Inc., a biotechnology company engaging the autophagy and lysosomal systems to develop innovative new medicines, today announced the nomination of its first development candidate, ...

Research shows intentional weight loss in older adults can lead to better mobility, reduced medical complications, and ...

The global ablation technology market was valued at US$ 6.82 billion in 2024 and is projected to reach US$ 16.74 billion by 2034, growing at a CAGR of 9.82% ...

Texts like Job 36:32 (God “fills his hands with lightning”) and Genesis 9:11 (God’s promise not to flood the Earth again) were taken to mean that human efforts to prevent disasters—like lightning rods ...